Acetaminophen and Ibuprofen — Competitive Intelligence Brief

Acetaminophen and Ibuprofen (Acetaminophen and Ibuprofen) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Analgesic/Antipyretic combination (NSAID + non-NSAID). Area: Pain Management, Fever Reduction.

marketed Analgesic/Antipyretic combination (NSAID + non-NSAID) Prostaglandin synthesis pathway; COX-1/COX-2 enzymes Pain Management, Fever Reduction Small molecule

Target snapshot

Acetaminophen and Ibuprofen (Acetaminophen and Ibuprofen) — University of Manitoba. Acetaminophen and ibuprofen work together to reduce pain and fever through complementary mechanisms: acetaminophen inhibits prostaglandin synthesis in the central nervous system, while ibuprofen inhibits peripheral cyclooxygenase enzymes.

Comparator set (1 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Acetaminophen and Ibuprofen TARGET	Acetaminophen and Ibuprofen	University of Manitoba	marketed	Analgesic/Antipyretic combination (NSAID + non-NSAID)	Prostaglandin synthesis pathway; COX-1/COX-2 enzymes
Acetaminophen/Ibuprofen	Acetaminophen/Ibuprofen	Seoul National University Hospital	marketed	Analgesic/Antipyretic combination (NSAID + non-NSAID)	Cyclooxygenase-1 (COX-1), Cyclooxygenase-2 (COX-2), prostaglandin synthesis pathways

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Analgesic/Antipyretic combination (NSAID + non-NSAID) class)

1. Seoul National University Hospital · 1 drug in this class
2. University of Manitoba · 1 drug in this class